ACMR · XBRL financial data

ACM Research financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ACMR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	157	260	389	558	782	901
Cost of revenue	87	145	205	282	391	501
Gross profit	70	115	184	276	392	400
Research and development	19	34	62	93	105	145
General and administrative	12	15	22	41	70	69
Total operating expenses	48	76	125	180	241	291
Operating income (loss)	21	39	59	96	151	109
Interest income	1	1	9	8	10	15
Interest expense	1	1	2	3	4	7
Other income (expense)	(3)	(1)	3	(2)	6	(10)
Income tax expense (benefit)	(2)	0	17	19	35	13
Net income (loss)	19	38	39	77	104	94
Earnings per share, basic‡ USD per share	0.11	0.22	0.66	1.29	1.67	1.47
Earnings per share, diluted‡ USD per share	0.10	0.19	0.59	1.16	1.53	1.37
Weighted average shares, basic‡ millions of shares	164	173	59	60	62	64
Weighted average shares, diluted‡ millions of shares	191	196	65	65	66	67

‡ Per-share figures and share counts are adjusted for the 3-for-1 stock split (March 2021); filings made before it reported them unadjusted.
‡ Per-share figures and share counts are adjusted for the 3-for-1 stock split (March 2022); filings made before it reported them unadjusted.
† Share count changed about 1/3 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ACMR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	72	563	248	182	407	757
Short-term investments	—	—	20	21	19	36
Marketable securities	28	29	20	—	—	—
Marketable securities, non-current	—	—	—	—	5	10
Accounts receivable	56	106	183	283	387	504
Inventory	89	218	393	545	598	703
Prepaid and other current assets	—	—	—	—	8	11
Total current assets	261	953	964	1,176	1,483	2,437
Property and equipment, net	8	14	83	202	269	315
Right-of-use asset	4	4	2	7	14	18
Total assets	341	1,052	1,236	1,491	1,856	2,872
Accounts payable	36	101	102	—	—	—
Current portion of long-term debt	2	2	2	7	44	35
Total current liabilities	103	206	396	501	641	746
Long-term debt	18	23	19	54	106	179
Lease liability, non-current	3	2	1	4	4	5
Total liabilities	133	241	423	565	760	942
Retained earnings	34	72	94	157	260	350
Total stockholders' equity	141	676	675	767	905	1,464
Total liabilities and equity	341	1,052	1,236	1,491	1,856	2,872

† Share count changed about 1/3 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

Fiscal years (ACMR's year ends in late December)

In millions of dollars	FY 2020Dec 31, 2020	FY 2021Dec 31, 2021	FY 2022†Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	19	38	39	77	104	94
Stock-based compensation	6	5	8	27	50	34
Depreciation and amortization	—	—	5	7	7	14
Net cash from operating activities	(14)	(40)	(62)	(75)	152	(10)
Purchases of property and equipment	5	9	91	62	82	56
Net cash from investing activities	(70)	(11)	(266)	(7)	(12)	(390)
Proceeds from issuing common stock	0	0	—	—	—	—
Share repurchases	0	0	—	—	—	—
Proceeds from long-term debt	20	7	0	42	97	119
Repayments of long-term debt	—	—	2	2	10	60
Net cash from financing activities	33	539	46	19	92	742
Net change in cash	(46)	491	(315)	(65)	228	355

† Share count changed about 1/3 in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.

SIC 3559 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3559 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Runway	Quarter
ACM Research	969	293	(6.4)*	not reported	169.0 quarters	Q2 FY26 10-QJun 30, 2026
Veeco Instruments	214	not reported	51*	61.1M	—	Q2 FY26 10-QJun 30, 2026
Azenta	190	161	1.4*	43.8M	—	Q3 FY26 10-QJun 30, 2026
Axcelis Technologies	155	215	18*	30.9M	—	Q2 FY26 10-QJun 30, 2026
Energy Recovery	61	12	16*	51.0M	—	Q2 FY26 10-QJun 30, 2026
Kadant	135	313	54*	11.8M	—	Q2 FY26 10-QJul 4, 2026
Cricut	267	156	50*	209.4M	—	Q2 FY26 10-QJun 30, 2026
JBT Marel	117	994	99*	51.1M	—	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.